The new Medicare 'Access' code for AI in chronic care is priced too low to be profitable if humans are kept in the loop. This clever incentive design forces providers to adopt genuine AI-driven leverage rather than simply relabeling human effort, a first for healthcare technology.

AI's most significant impact won't be on broad population health management, but as a diagnostic and decision-support assistant for physicians. By analyzing an individual patient's risks and co-morbidities, AI can empower doctors to make better, earlier diagnoses, addressing the core problem of physicians lacking time for deep patient analysis.

The next evolution in personalized medicine will be interoperability between personal and clinical AIs. A patient's AI, rich with daily context, will interface with their doctor's AI, trained on clinical data, to create a shared understanding before the human consultation begins.

The most significant opportunity for AI in healthcare lies not in optimizing existing software, but in automating 'net new' areas that once required human judgment. Functions like patient engagement, scheduling, and symptom triage are seeing explosive growth as AI steps into roles previously held only by staff.

Insurers use AI to auto-deny claims and require tedious phone calls for appeals. Lunabill provides hospitals with an AI voice bot to automate these calls. This creates an arms race where one company's AI will inevitably negotiate with another's, foreshadowing a future where many adversarial B2B processes become fully automated AI-to-AI interactions.

Existing healthcare datasets like claims are flawed proxies. The most valuable, untapped data will come from new sources like AI scribe encounters and patient-uploaded data into modern PHRs. This 'ground truth' data will unlock novel applications like usage-based malpractice insurance.

An "AI arms race" is underway where stakeholders apply AI to broken, adversarial processes. The true transformation comes from reinventing these workflows entirely, such as moving to real-time payment adjudication where trust is pre-established, thus eliminating the core conflict that AI is currently used to fight over.

Chronic disease patients face a cascade of interconnected problems: pre-authorizations, pharmacy stockouts, and incomprehensible insurance rules. AI's potential lies in acting as an intelligent agent to navigate this complex, fragmented system on behalf of the patient, reducing waste and improving outcomes.

Initially adopted for clinician retention, AI tools are now proving hard financial ROI. By unlocking new operating margin, AI allows health systems to reinvest in talent and technology. This creates a compounding flywheel that separates top organizations from those at risk of consolidation.